The IPI549-loaded hydrogel can reshape the tumor immune microenvironment (TIME) by reducing the presence of CD11b+ immunosuppressive cells (including myeloid-derived suppressor cells and tumor-associated macrophages (TAMs)) and enhancing the infiltration of CD8+ T cells (Figure 3G,H). Here, CD8A is linked to neoplasm.